Pham Tran Phuong

Pham Tran Phuong

Auto-generated profile, based on publicly available information

Pham Tran Phuong

Department of Cardiovascular Medicine Tokushima University Graduate School of Biomedical Sciences Tokushima Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
PPPhuong Tran Pham
Phuong Tran Pham
DFDaiju Fukuda
Daiju Fukuda
SNSachiko Nishimoto
Sachiko Nishimoto
JKJoo-Ri Kim-Kaneyama
Joo-Ri Kim-Kaneyama
XLXiao-Feng Lei
Xiao-Feng Lei
MSMasataka Sata
Masataka Sata
Lifestyle-related diseases promote atherosclerosis, a chronic inflammatory disease; however, the molecular mechanism remains largely unknown. Endogenous DNA fragments released under over-nutrient condition provoke sterile inflammation through the recognition by DNA sensors. Here, we investigated the role of stimulator of interferon genes (STING), a cytosolic DNA sensor, in atherogenesis. Apolipoprotein E-deficient (Apoe−/−) mice fed a western-type diet (WTD), a hypercholesterolaemic mouse model, showed higher STING expression and markers for DNA damage such as γH2AX, p53, and single-stranded DNA (ssDNA) accumulation in macrophages in the aorta compared with wild-type (WT) mice. The level of cGAMP, a STING agonist, in the aorta was higher in Apoe−/− mice. Genetic deletion of Sting in Apoe−/− mice reduced atherosclerotic lesions in the aortic arch, lipid, and macrophage accumulation in plaques, and inflammatory molecule expression in the aorta compared with the control. Pharmacological blockade of STING using a specific inhibitor, C-176, ameliorated atherogenesis in Apoe−/− mice. In contrast, bone marrow-specific STING expression in Apoe−/− mice stimulated atherogenesis. Expression or deletion of STING did not affect metabolic parameters and blood pressure. In vitro studies revealed that STING activation by cGAMP or mitochondrial DNA accelerated inflammatory molecule expression (e.g. TNF-α or IFN-β) in mouse and human macrophages. Activation of nuclear factor-κB and TANK binding kinase 1 was involved in STING-associated vascular inflammation and macrophage activation. Furthermore, human atherosclerotic lesions in the carotid arteries expressed STING and cGAMP. Stimulator of interferon genes stimulates pro-inflammatory activation of macrophages, leading to the development of atherosclerosis. Stimulator of interferon genes signalling may serve as a potential therapeutic target for atherosclerosis. STING signalling, originally associated with innate immune system, may provide a novel mechanism of atherogenesis by linking lifestyle-related diseases to chronic inflammatory disease and serve as a potential therapeutic target for atherosclerosis.

1 January 2015 in Biomedical Research
Verified
Journal Article
Closed access
TLThi Kim Chung LE
Thi Kim Chung LE
THToshio Hosaka
Toshio Hosaka
TNThanh Trung Nguyen
Thanh Trung Nguyen
AKAfework Kassu
Afework Kassu
TDThi Oanh Dang
Thi Oanh Dang
XPXuan Da Pham
Xuan Da Pham
This study, using C57BL/6J mice with streptozotocin (STZ)-induced diabetes, aimed to determine whether Bifidobacterium species (spp.) both induces the expressions of proteins in the insulin signaling pathway and enhances the expressions of certain adipocytokines. The protein expressions of IκB kinase alpha (IKKα), IκB kinase beta (IKKβ), nuclear factor-kappaB inhibitor alpha (IκBα), and the mitogen-activated protein kinase (MAPK) pathway were also investigated. Oral administration of Bifidobacterium spp. reduced blood glucose levels significantly and increased the protein expressions of insulin receptor beta, insulin receptor substrate 1, protein kinase B (Akt/PKB), IKKα, and IκBα. Extracellular-signal-regulated kinase 2 (ERK2) showed increased expression. Bifidobacterium spp. also induced the adiponectin expression and decreased both macrophage chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) expression. In addition, IKKβ, c-Jun NH2-terminal kinase (JNK) and p38 MAP kinase expressions showed no significant changes in both groups. In conclusion, Bifidobacterium spp. may be the promising bacteria for treating diabetes.

16 October 2018 in Circulation
Verified
Journal Article
Closed access
PDF file
THTomoya Hara
Tomoya Hara
PPPham Tran Phuong
Pham Tran Phuong
DFDaiju Fukuda
Daiju Fukuda
KYKoji Yamaguchi
Koji Yamaguchi
CMChie Murata
Chie Murata
MSMasataka Sata
Masataka Sata
Background: The coagulation system is closely linked with vascular inflammation, although the underlying mechanisms are still obscure. Recent studies show that protease-activated receptor (PAR)-2, a major receptor of activated factor X, is expressed in both vascular cells and leukocytes, suggesting that PAR-2 may contribute to the pathogenesis of inflammatory diseases. Here we investigated the role of PAR-2 in vascular inflammation and atherogenesis.Methods: We generated apolipoprotein E-deficient (ApoE-/-) mice lacking systemic PAR-2 expression (PAR-2-/-ApoE-/-). ApoE-/-mice, which lack or express PAR-2 only in bone marrow (BM) cells, were also generated by BM transplantation. Atherosclerotic lesions were investigated after 20 weeks on a Western-type diet by histological analyses, quantitative reverse transcription polymerase chain reaction, and Western blotting. In vitro experiments using BM-derived macrophages were performed to confirm the proinflammatory roles of PAR-2. The association between plasma activated factor X level and the severity of coronary atherosclerosis was also examined in humans who underwent coronary intervention.Results: PAR-2-/-ApoE-/-mice showed reduced atherosclerotic lesions in the aortic arch (P<0.05) along with features of stabilized atherosclerotic plaques, such as less lipid deposition (P<0.05), collagen loss (P<0.01), macrophage accumulation (P<0.05), and inflammatory molecule expression (P<0.05) compared withApoE-/-mice. Systemic PAR2 deletion inApoE-/-mice significantly decreased the expression of inflammatory molecules in the aorta. The results of BM transplantation experiments demonstrated that PAR-2 in hematopoietic cells contributed to atherogenesis inApoE-/-mice. PAR-2 deletion did not alter metabolic parameters. In vitro experiments demonstrated that activated factor X or a specific peptide agonist of PAR-2 significantly increased the expression of inflammatory molecules and lipid uptake in BM-derived macrophages from wild-type mice compared with those from PAR-2–deficient mice. Activation of nuclear factor-κB signaling was involved in PAR-2–associated vascular inflammation and macrophage activation. In humans who underwent coronary intervention, plasma activated factor X level independently correlated with the severity of coronary atherosclerosis as determined by Gensini score (P<0.05) and plaque volume (P<0.01).Conclusions: PAR-2 signaling activates macrophages and promotes vascular inflammation, increasing atherosclerosis inApoE-/-mice. This signaling pathway may also participate in atherogenesis in humans.

26 September 2014 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
TBTran Quang Binh
Tran Quang Binh
PPPham Tran Phuong
Pham Tran Phuong
BNBui Thi Nhung
Bui Thi Nhung
TDTung Dinh Do
Tung Dinh Do
Metabolic syndrome (MetS) is a clustering of metabolic risk factors for cardiovascular diseases and type 2 diabetes. The study aimed to estimate the prevalence of MetS, its components, and their associations among rural middle-aged population in Vietnam.

1 January 2013 in Gene
Verified
Journal Article
Closed access
TBTran Quang Binh
Tran Quang Binh
PPPham Tran Phuong
Pham Tran Phuong
BNBui Thi Nhung
Bui Thi Nhung
DTDang Dinh Thoang
Dang Dinh Thoang
HLHa Thi Lien
Ha Thi Lien
DTDuong Van Thanh
Duong Van Thanh

1 August 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PPPhuong Tran Pham
Phuong Tran Pham
DFDaiju Fukuda
Daiju Fukuda
SYShusuke Yagi
Shusuke Yagi
KKKenya Kusunose
Kenya Kusunose
HYHirotsugu Yamada
Hirotsugu Yamada
MSMasataka Sata
Masataka Sata
Activated factor X (FXa) plays a central role in the coagulation cascade, while it also mediates vascular function through activation of protease-activated receptors (PARs). Here, we examined whether inhibition of FXa by rivaroxaban, a direct FXa inhibitor, attenuates endothelial dysfunction in streptozotocin (STZ)-induced diabetic mice. Induction of diabetes increased the expression of a major FXa receptor, PAR2, in the aorta (P < 0.05). Administration of rivaroxaban (10 mg/kg/day) to diabetic wild-type (WT) mice for 3 weeks attenuated endothelial dysfunction as determined by acetylcholine-dependent vasodilation compared with the control (P < 0.001), without alteration of blood glucose level. Rivaroxaban promoted eNOSSer1177phosphorylation in the aorta (P < 0.001). Induction of diabetes to PAR2-deficient (PAR2−/−) mice did not affect endothelial function and eNOSSer1177phosphorylation in the aorta compared with non-diabetic PAR2−/−mice. FXa or a PAR2 agonist significantly impaired endothelial function in aortic rings obtained from WT mice, but not in those from PAR2−/−mice. FXa promoted JNK phosphorylation (P < 0.01) and reduced eNOSSer1177phosphorylation (P < 0.05) in human coronary artery endothelial cells (HCAEC). FXa-induced endothelial dysfunction in aortic rings (P < 0.001) and eNOSSer1177phosphorylation (P < 0.05) in HCAEC were partially ameliorated by a JNK inhibitor. Rivaroxaban ameliorated diabetes-induced endothelial dysfunction. Our results suggest that FXa or PAR2 is a potential therapeutic target.